Biotechnology Analyst Biegler, along with Dr. Giancarlo Moscol, Associate Professor in the Department of Breast Medical Oncology at MD Anderson Cancer Center, discuss LLY‘s upcoming EMBER-3 data from LLY, its potential to reshape the standard-of-care, and key insights from looming readouts at San Antonio Breast Cancer Symposium (SABCS) on an Analyst/Industry conference call to be held on November 21 at 4 pm.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LLY:
- Eli Lilly, Verge announce milestones in ALS collaboration
- Eli Lilly & Co Appoints Procter & Gamble CEO to Board
- Eli Lilly appoints Jon Moeller to board of directors
- Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
- Lilly’s muvalaplin lowered lipoprotein(a) levels in adults in Phase 2 trial
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
